Literature DB >> 15138705

[A rare case of a neuroendocrine carcinoma of the esophagus. Intermediate between a well-differentiated neuroendocrine carcinoma and a low-differentiated neuroendocrine carcinoma].

T Gumprich1, G Johnen, T Hummel, M Jaworska, I Schmitz, K-M Müller.   

Abstract

We report a rare case of a neuroendocrine carcinoma located in the esophagus of a 62-year-old male patient. The initial diagnosis of a "small-cell tumor" was based on biopsy. Our diagnosis was based on the histomorphological examination of the resected material. Diagnostic criteria were the characteristic solid or clustered growth patterns, monomorphic cell nuclei, lack of necrosis, immunohistochemical detection of neuroendocrine markers like chromogranin, synaptophysin and neuron-specific enolase (NSE) as well as detection of cytoplasmic neuroendocrine granules by electron microscopy. In addition, we found an increased prolific activity by staining with Ki67 antigen. 30% of the cell nuclei displayed a positive reaction. Focal invasion of blood vessels was also detected. With 17 different chromosomal imbalances, comparative genomic hybridization (CGH) revealed a malignant tumor stage that was not visible at the microscopic level. According to the new WHO classification of neuroendocrine tumors the described tumor was identified as an intermediate between a well-differentiated neuroendocrine carcinoma and a low-differentiated neuroendocrine carcinoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15138705     DOI: 10.1007/s00292-003-0662-5

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  24 in total

Review 1.  [Gastroenteropancreatic neuroendocrine/endocrine tumors. Current pathologic-diagnostic view].

Authors:  A Schmitt-Gräff; R Nitschke; B Wiedenmann
Journal:  Pathologe       Date:  2001-03       Impact factor: 1.011

Review 2.  Revised classification of neuroendocrine tumours of the lung, pancreas and gut.

Authors:  C Capella; P U Heitz; H Höfler; E Solcia; G Klöppel
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

3.  Malignant carcinoid of oesophagus.

Authors:  A Siegal; A Swartz
Journal:  Histopathology       Date:  1986-07       Impact factor: 5.087

4.  [Carcinoid syndrome in primary esophageal tumor].

Authors:  K Broicher; H A Hienz
Journal:  Z Gastroenterol       Date:  1974-09       Impact factor: 2.000

5.  Pathologic analysis of carcinoids. Histologic reevaluation of 62 cases.

Authors:  J Soga; K Tazawa
Journal:  Cancer       Date:  1971-10       Impact factor: 6.860

6.  Carcinoid of esophagus.

Authors:  S Brenner; H Heimlich; M Widman
Journal:  N Y State J Med       Date:  1969-05-15

Review 7.  [Classification of neuroendocrine tumors of the gastrointestinal tract and pancreas and its therapeutic relevance].

Authors:  H Höfler; A Stier; V Schusdziarra; J R Siewert
Journal:  Chirurg       Date:  1997-02       Impact factor: 0.955

8.  [Morphology, DNA cytophotometry and prognosis in gastrointestinal neuroendocrine tumours (carcinoids). A clinico-pathological study of 95 patients].

Authors:  B C Padberg; C Städtler; W Jochum; S Schröder
Journal:  Pathologe       Date:  2000-01       Impact factor: 1.011

Review 9.  Atypical carcinoid of the esophagus: a case report and review of the literature.

Authors:  G M Lindberg; K H Molberg; M F Vuitch; J Albores-Saavedra
Journal:  Cancer       Date:  1997-04-15       Impact factor: 6.860

10.  Oat cell carcinoma of esophagus: a report of six British patients with a review of the literature.

Authors:  M A Doherty; M McIntyre; S J Arnott
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-01       Impact factor: 7.038

View more
  2 in total

1.  [Neuroendocrine tumors].

Authors:  W Saeger
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

2.  [Primary metastatic renal metastatic carcinoid tumor in a young male patient: a contribution to the differential diagnosis of neuroendocrine tumors].

Authors:  M L Gross; I Berger
Journal:  Pathologe       Date:  2007-07       Impact factor: 1.011

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.